NovaBridge Biosciences
NBP
$2.06
-$0.04-1.91%
NASDAQ
| 12/31/2025 | 09/30/2025 | 12/31/2024 | 12/31/2024 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -967.05% | -- | -- | 47.08% | -- |
| Total Depreciation and Amortization | 0.00% | -- | -- | 8.67% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3,178.52% | -- | -- | -92.43% | -- |
| Change in Net Operating Assets | 46.95% | -- | -- | -106.28% | -- |
| Cash from Operations | -893.69% | -- | -- | -230.00% | -- |
| Capital Expenditure | -- | -- | -- | -3,700.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 99.91% | -- |
| Cash from Investing | -- | -- | -- | 99.87% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.68% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -233.64% | -- | -- | -- | -- |
| Cash from Financing | -104.98% | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | 156.16% | -- | -- | -101.00% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -127.82% | -- | -- | 84.77% | -- |